Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Learn what to do in the last years before retirement to maximize your savings and prepare for a fulfilling retirement. Start planning now!
22,081 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
XRP has clawed back from a fresh 19-month low, trading near $1.13 after a sharp drop to $1.05. Analysts warn the path...
When a company's CFO makes a notable stock purchase, investors pay attention. This article breaks down what nomad foo...
Budget missteps happen to everyone. This guide shows you how to learn from budgeting mistakes, fix overspending, and ...
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...
Circle has delivered a dramatic swing in 2024. This article breaks down the main reason it could keep climbing, the r...
Micron's stock jumped more than 600% in a year, sparking a lively debate about a possible stock split. This guide bre...
Syscoin faces a dramatic breach after a bridge exploit minted billions of unauthorized tokens, unleashing a sharp pri...
A single AI infrastructure stock delivered an eye-popping 4,800% gain in 12 months. Here’s what drove that rally, wha...
A White House meeting with Senate lawmakers failed to finalize ethics language tied to the Digital Asset Market Clari...
Ripple faces a pivotal week as XRP tests critical support near $1 and resistance at $1.40. Analysts publish ripple (x...
When a stock pops today, investors want the real story behind the move. This guide breaks down what drove SLB stock t...